VRTX Historical PE Ratio image   This VRTX PE ratio history page last updated 8/8/2022
VRTX Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2022
8/4/2022
274.853.6014.4019.1
Q1 2022
5/5/2022
266.373.5214.0818.9
Q4 2021
1/26/2022
226.583.3713.4816.8
Q3 2021
11/2/2021
181.403.5614.2412.7
Q2 2021
7/29/2021
200.383.1112.4416.1
Q1 2021
4/29/2021
211.862.9811.9217.8
Q4 2020
2/1/2021
231.772.5110.0423.1
Q3 2020
10/29/2020
207.012.6410.5619.6
Q2 2020
7/30/2020
279.402.6110.4426.8
Q1 2020
4/29/2020
251.052.5610.2424.5
Q4 2019
1/30/2020
230.311.706.8033.9
Q3 2019
10/30/2019
199.281.234.9240.5
Q2 2019
7/31/2019
166.621.265.0433.1
Q1 2019
4/30/2019
168.981.144.5637.1
Q4 2018
2/5/2019
187.021.305.2036.0
Q3 2018
10/24/2018
163.091.094.3637.4
Q2 2018
7/25/2018
176.810.943.7647.0
Q1 2018
4/26/2018
158.810.763.0452.2
Q4 2017
1/31/2018
166.870.612.4468.4
Q3 2017
10/25/2017
146.800.532.1269.2
Q2 2017
7/26/2017
163.420.391.56104.8
Q1 2017
4/27/2017
117.420.411.6471.6
Q4 2016
1/25/2017
85.190.351.4060.9
Q3 2016
10/25/2016
78.710.160.64123.0
Q2 2016
7/27/2016
96.010.240.96100.0
Q1 2016
4/27/2016
84.500.090.36234.7
Q4 2015
1/27/2016
92.500.170.68136.0
Q3 2015
10/28/2015
120.10-0.13-0.52NA
Q2 2015
7/29/2015
125.62-0.54-2.16NA
Q1 2015
4/29/2015
123.76-0.62-2.48NA
Q4 2014
1/28/2015
121.26-0.55-2.20NA
Q3 2014
10/28/2014
114.07-0.37-1.48NA
Q2 2014
7/29/2014
95.56-0.68-2.72NA
Q1 2014
5/1/2014
68.95-1.00-4.00NA
Q4 2013
1/29/2014
78.820.190.76103.7
Q3 2013
10/29/2013
76.09-0.32-1.28NA
Q2 2013
7/29/2013
79.66-0.03-0.12NA
Q1 2013
4/30/2013
76.820.030.12>500
Q4 2012
1/29/2013
46.390.040.16289.9
Q3 2012
11/1/2012
50.48-0.27-1.08NA
Q2 2012
7/30/2012
49.960.461.8427.2
Q1 2012
4/26/2012
37.520.552.2017.1
VRTX PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2022
8/4/2022
274.853.6014.0519.6
Q1 2022
5/5/2022
266.373.5213.5619.6
Q4 2021
1/26/2022
226.583.3713.0217.4
Q3 2021
11/2/2021
181.403.5612.1614.9
Q2 2021
7/29/2021
200.383.1111.2417.8
Q1 2021
4/29/2021
211.862.9810.7419.7
Q4 2020
2/1/2021
231.772.5110.3222.5
Q3 2020
10/29/2020
207.012.649.5121.8
Q2 2020
7/30/2020
279.402.618.1034.5
Q1 2020
4/29/2020
251.052.566.7537.2
Q4 2019
1/30/2020
230.311.705.3343.2
Q3 2019
10/30/2019
199.281.234.9340.4
Q2 2019
7/31/2019
166.621.264.7934.8
Q1 2019
4/30/2019
168.981.144.4737.8
Q4 2018
2/5/2019
187.021.304.0945.7
Q3 2018
10/24/2018
163.091.093.4048.0
Q2 2018
7/25/2018
176.810.942.8462.3
Q1 2018
4/26/2018
158.810.762.2969.3
Q4 2017
1/31/2018
166.870.611.9486.0
Q3 2017
10/25/2017
146.800.531.6887.4
Q2 2017
7/26/2017
163.420.391.31124.7
Q1 2017
4/27/2017
117.420.411.16101.2
Q4 2016
1/25/2017
85.190.350.84101.4
Q3 2016
10/25/2016
78.710.160.66119.3
Q2 2016
7/27/2016
96.010.240.37259.5
Q1 2016
4/27/2016
84.500.09-0.41NA
Q4 2015
1/27/2016
92.500.17-1.12NA
Q3 2015
10/28/2015
120.10-0.13-1.84NA
Q2 2015
7/29/2015
125.62-0.54-2.08NA
Q1 2015
4/29/2015
123.76-0.62-2.22NA
Q4 2014
1/28/2015
121.26-0.55-2.60NA
Q3 2014
10/28/2014
114.07-0.37-1.86NA
Q2 2014
7/29/2014
95.56-0.68-1.81NA
Q1 2014
5/1/2014
68.95-1.00-1.16NA
Q4 2013
1/29/2014
78.820.19-0.13NA
Q3 2013
10/29/2013
76.09-0.32-0.28NA
Q2 2013
7/29/2013
79.66-0.03-0.23NA
Q1 2013
4/30/2013
76.820.030.26295.5
Q4 2012
1/29/2013
46.390.040.7859.5
Q3 2012
11/1/2012
50.48-0.27NANA
Q2 2012
7/30/2012
49.960.46NANA
Q1 2012
4/26/2012
37.520.55NANA
Quotes delayed 20 minutes

Email EnvelopeFree VRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Vertex Pharmaceuticals (VRTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VSTM PE Ratio History
VTGN PE Ratio History
VTRS PE Ratio History
VTVT PE Ratio History
VVOS PE Ratio History
VXRT PE Ratio History
VYGR PE Ratio History
VYNE PE Ratio History
VYNT PE Ratio History
WAT PE Ratio History
How should the VRTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Vertex Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this VRTX Historical PE Ratio page.

What is the average historical PE for VRTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The VRTX historical PE ratio using the annualized quarterly earnings method works out to 61.9.

What is the average historical PE for VRTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The VRTX historical PE ratio using the TTM earnings method works out to 68.2.

What is the average historical PE for VRTX based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The VRTX historical PE ratio using the annualized median TTM earnings method works out to 14.16.

On this page we presented the VRTX Historical PE Ratio information for Vertex Pharmaceuticals' stock. The average VRTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 61.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VRTX historical PE based on this TTM earnings result method is 68.2. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VRTX historical PE result, against the recent PE: when this page was posted on 8/5/2022, the most recent closing price for VRTX had been 288.03, and the most recent quarterly earnings result, annualized, was 14.4. Meanwhile, the most recent TTM earnings summed to 14.05. From these numbers, we calculate the recent VRTX PE on 8/5/2022 based on annualized quarterly EPS was 20.0. Based on VRTX's history, that recent PE is low relative to the historical average, with the recent PE 67.7% lower than the historical average PE across our data set for Vertex Pharmaceuticals. Looking at the recent VRTX PE on 8/5/2022 based on TTM EPS, we calculate the ratio at 20.5. Based on VRTX's history, that recent PE is low relative to the historical average, with the recent PE 69.9% lower than the average PE across our Vertex Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting VRTX historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for VRTX, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for VRTX, we start with the past four EPS numbers and we first sort them from lowest to highest: 3.37, 3.52, 3.56, and 3.60. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 3.52 and 3.56 — which gives us the median of 3.54. Basically the way to think about this 3.54 number is this: for the trailing four earnings reports, 3.54 marks the "middle ground" number where VRTX has reported a value higher than 3.54 half the time, and has reported a value lower than 3.54 half the time. Annualizing that median value then gets us to 14.16/share, which we use as the denominator in our next PE calculation. With 288.03 as the numerator (as of 8/5/2022), the calculation is then 288.03 / 14.16 = 20.3 as the VRTX PE ratio as of 8/5/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on VRTX or any other given stock, valuation analysis for VRTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Vertex Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VRTX. Thanks for visiting, and the next time you need to research VRTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: REX Split History, SEER Insider Buying, AGS Stock Predictions.

 

VRTX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.